Metformin Bluefish

Metformin, the active ingredient in Metformin Bluefish, is a Biguanide presented as an oral tablet for oral use. It is used to improve blood glucose control in adults with type 2 diabetes and can also be prescribed for polycystic ovary syndrome.

GNH USA supplies Metformin Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin is indicated for conditions affecting glucose metabolism and insulin sensitivity. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Polycystic ovary syndrome: improves insulin resistance and may restore ovulatory function. - Prediabetes: reduces the risk of progression to type 2 diabetes by improving glycaemic control.

Metformin is associated with a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or diarrhoea. - Metallic taste in the mouth. - Mild headache.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening metabolic disturbance. - Severe skin reactions such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Vitamin B12 deficiency with long‑term use.

Metformin should be used with careful clinical monitoring and patient education. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic disease: avoid in patients with significant liver impairment. - Cardiovascular status: use cautiously in patients with unstable heart failure. - Alcohol intake: limit consumption to reduce risk of lactic acidosis. - Pregnancy and lactation: evaluate risk‑benefit ratio; use only if clearly needed. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Metformin may interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: can precipitate acute renal failure, increasing lactic acidosis risk. - Cimetidine: may raise metformin plasma concentrations.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance renal effects; monitor kidney function. - Beta‑blockers: can mask hypoglycaemia symptoms. - Diuretics: may affect renal clearance of metformin. - Alcohol: potentiates lactic acidosis risk, especially with chronic use.